Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

324.71 +0.48 (+0.15%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Week In Review: Henlius Signs $196 Million Deal For Two Oncology Bifunctional Sialidase Candidates
Shanghai Henlius Biotech acquired Greater China rights to two early-stage bifunctional sialidase candidates from Palleon Pharma, a Waltham, MA biopharma, in a deal with $196.5 million in development... 
Via Talk Markets
What Are Whales Doing With Eli Lilly
A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 14 strange trades. 
Via Benzinga
SWOT Analysis on Diabetes Devices Sales Market Revenue 2022-2029 : Medtronic, Sanofi, Novo Nordisk, Medtronic
Global Diabetes Devices Market Research 2022-2031 published by Calibre Research studies the current situation, Diabetes Devices market size, share, trends, regional growth and the latest technologies... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
If You Invested $100 In This Stock 5 Years Ago, You Would Have $400 Today
Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 21.93% on an annualized basis producing an average annual return of 31.32%. Currently, Eli Lilly has a market capitalization of... 
Via Benzinga
Sanofi Lowers Out-Of-Pocket Insulin Cost For Uninsured Patients
 
Via Benzinga
BMO Sees 'Differentiated Gene Editing Platform' For This Small-Cap Stock
 
Via Benzinga
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
5 S&P 500 Stocks Ready to Break Out
Although Wall Street is hurting right now, not all S&P 500 stocks are getting thrashed. And these beauties are getting ready to break out. 
Via InvestorPlace
Check Out What Whales Are Doing With LLY
Someone with a lot of money to spend has taken a bearish stance on Eli Lilly (NYSE:LLY). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
7 Defensive Stocks to Buy for a Bear Market
As Wall Street gets ready for another earnings season, investors are increasingly chasing after defensive stocks to buy for a bear market. 
Via InvestorPlace
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
More than four in 10 people in a recent survey knew of someone with long Covid. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Executives Sell More Than $67M Of 5 Stocks: NetApp, Eli Lilly And More
US gold futures traded lower on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
This Is What Whales Are Betting On Eli Lilly
A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 17 strange trades. 
Via Benzinga
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. 
Via Talk Markets
Peering Into Eli Lilly's Recent Short Interest
Eli Lilly's (NYSE:LLY) short percent of float has risen 4.76% since its last report. The company recently reported that it has 5.23 million shares sold short, which is 0.66% of... 
Via Benzinga
Jim Cramer Says This Company Is A Great One
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Woodside Energy Group Ltd (NYSE: WDS) is a great company, with a great yield. 
Via Benzinga
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
 
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $5,000 Today
Eli Lilly (NYSE:LLY) has outperformed the market over the past 15 years by 5.21% on an annualized basis producing an average annual return of 11.42%. Currently, Eli Lilly has a market capitalization of... 
Via Benzinga
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Tuesday, June 14
CNBC 
Via Benzinga
Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy
Alopecia areata, an autoimmune disorder that causes patchy hair loss, now has a new treatment that has been approved by the Food and Drug Administration. 
Via Benzinga
Looking At Eli Lilly's Recent Whale Trades
A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 35 strange trades. 
Via Benzinga
Stock Market Rally Under Pressure As Indexes Tumble, Breakouts Fail: Weekly Review
The 10-year Treasury yield soared above 3% as inflation came in hot. 
Via Investor's Business Daily
7 Great ETFs to Buy Now for Momentum in Q2
These seven ETFs to buy are among the best funds. YPS, BITQ, FMET, QQMG, DVY, XSD, and VHT can make excellent investments. 
Via InvestorPlace
CNBC's Final Trades: Sabra Health Care, Eli Lilly, FedEx And This Way To Gain EV Exposure
On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Sabra Health Care REIT Inc (NASDAQ: SBRA) has an 8.5% yield an 
Via Benzinga
We're Looking At Obesity In A New Way — And 4 Pharmaceutical Stocks Could Benefit
The conversation around obesity is changing. Two diabetes drug makers are at the forefront. 
Via Investor's Business Daily
6 Stocks Moved By Traders On 'Fast Money Halftime Report'
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned.... 
Via Benzinga
Don't Trade This Stock Market
Stocks and the stock market as a whole have traded sideways for the past eight trading sessions. What will be the next big move that the stock market makes? 
Via Talk Markets
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
Image provided by Pexels 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.